These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5384122)

  • 1. [Pharmacy committees and the prescription of drugs].
    Boréus LO
    Lakartidningen; 1969 Jun; 66():Suppl II:44+. PubMed ID: 5384122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 3. There is a trend in the utilization of psychotropics among elderly towards recommended drugs.
    Lesén E; Carlsten A
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1095-9. PubMed ID: 20712025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The chairman of the drug committees: limit the reporting requirement between pharmacy and the prescribing physician concerning generic drug exchange].
    Back S; Widäng K
    Lakartidningen; 2002 Dec; 99(49):5005. PubMed ID: 12522991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lists presented by eight drug committees compared. The number of preparations varies. Similar views on the most expensive drugs].
    Bergman U; Myrhed M
    Lakartidningen; 1996 Apr; 93(15):1459-60. PubMed ID: 8667738
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug committees in Sweden].
    Barkman R
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):1-3. PubMed ID: 5448711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug committees should be abolished because the reality has changed].
    Jönsson B; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Mar 14-20; 102(11):880-1; discussion 882-3. PubMed ID: 15835525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug committees in hospitals].
    Flatberg P
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):36-7. PubMed ID: 1111160
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are the drug committees sold?].
    Bystedt T; Gustavsson R
    Lakartidningen; 1993 Oct; 90(41):3518, 3523. PubMed ID: 8231491
    [No Abstract]   [Full Text] [Related]  

  • 11. [The drug committees will play a key role].
    Gennser M
    Lakartidningen; 1993 Nov; 90(46):4078, 4083. PubMed ID: 8259004
    [No Abstract]   [Full Text] [Related]  

  • 12. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of evidence-based medicine and implications for pharmacy & therapeutics committees.
    Williams K
    Manag Care Interface; 2007 Oct; 20(10):6-7. PubMed ID: 18405201
    [No Abstract]   [Full Text] [Related]  

  • 14. [Health economic evaluation of recommended drug treatment].
    Jendteg S; Persson U; Anell A
    Lakartidningen; 2002 Jul; 99(30-31):3130-1. PubMed ID: 12198934
    [No Abstract]   [Full Text] [Related]  

  • 15. The 'wise list'- a comprehensive model for drug and therapeutics committees to achieve adherence to recommendations for essential drugs among prescribers?
    Stichele RV
    Basic Clin Pharmacol Toxicol; 2011 Apr; 108(4):221-3. PubMed ID: 21414142
    [No Abstract]   [Full Text] [Related]  

  • 16. [More stringent requirements in connection with the choice of drugs. Members of the drug committees in Stockholm deliver an annual declaration of challengeability].
    Sjöqvist F
    Lakartidningen; 2001 Feb; 98(6):541-3. PubMed ID: 11475240
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new model of drug committees' activities developed in Gothenburg].
    Iwarson S
    Lakartidningen; 1996 Jul; 93(30-31):2649-50. PubMed ID: 8765777
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug committees are necessary, according to the SNS reference group].
    Allebeck P
    Lakartidningen; 2005 Apr 4-10; 102(14):1070. PubMed ID: 15892479
    [No Abstract]   [Full Text] [Related]  

  • 19. [What do the Swedish Drug and Therapeutics Committees think about cost savings?].
    Furängen A; Anders C
    Lakartidningen; 2010 Jul 21-Aug 10; 107(29-31):1790; author reply 1790. PubMed ID: 20812570
    [No Abstract]   [Full Text] [Related]  

  • 20. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.